We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 81-100 of 1,900 results
  1. Alginate Nanoparticles: A Potential Drug Carrier in Tuberculosis Treatment

    Among all infectious diseases that afflict humans, tuberculosis (TB) remains the deadliest. At present, epidemiologists estimate that one-third of...
    Rakesh P. Patel, Geeta K. Patel, ... Chuda Chittasupho in Tubercular Drug Delivery Systems
    Chapter 2023
  2. Dendrimers-Based Drug Delivery in Tuberculosis

    Tuberculosis (TB) is a disease caused by a microorganism (Mycobacterium tuberculosis) which invades the lungs and initiates the disease. Currently,...
    Dhaval J. Patel, Sunita Chaudhary, ... Jayvadan K. Patel in Tubercular Drug Delivery Systems
    Chapter 2023
  3. Solid Lipid Nanoparticles in Tuberculosis

    Tuberculosis (TB) is a deadly disease spread by single infection agents. It creates a huge burden on the healthcare system for the development of...
    Dhwani Rana, Sagar Salave, ... Jayvadan Patel in Tubercular Drug Delivery Systems
    Chapter 2023
  4. Global Health and Malaria: Past and Present

    Although malaria is a curable and preventable disease, it has wreaked havoc across the globe, affecting millions of people’s lives for decades since...
    Suryaveer Sankineni, Sarika Chauhan, ... Yashwant Pathak in Malarial Drug Delivery Systems
    Chapter 2023
  5. Surface-Modified Drug Delivery Systems in Malaria

    Due to the large number of individuals afflicted, the intricacy of the causative agent life cycle, the protist Plasmodium sp., and the severity of...
    Tayo Alex Adekiya, Pradeep Kumar, Yahya E. Choonara in Malarial Drug Delivery Systems
    Chapter 2023
  6. Clinical Trials in Malaria

    Clinical trials are the final and most important phase in the process of new drug development against any disease or disorder. Due to the development...
    Neelutpal Gogoi, Md. Kamaruz Zaman in Malarial Drug Delivery Systems
    Chapter 2023
  7. Polymeric Nanoparticles in Malaria

    The major reason behind malaria becoming one of the most serious infectious diseases is the limitations of available antimalarial therapy. Drug...
    Himanshu Paliwal, Bhupendra G. Prajapati, ... Jayvadan K. Patel in Malarial Drug Delivery Systems
    Chapter 2023
  8. Solid Lipid Nanoparticles in Malaria

    Malaria is a serious infectious disease that is caused due to Plasmodium parasites and is one of the major reasons for mortality due to infectious...
    Himanshu Paliwal, Bhupendra G. Prajapati, ... Mahavir Chougule in Malarial Drug Delivery Systems
    Chapter 2023
  9. Potential of Micro-/Nanoemulsions as a Delivery Carrier to Treat Malaria

    Malaria is a serious disease that exists since centuries. The drugs available for malaria therapy hold poor aqueous solubility and bioavailability...
    Vaibhavi Srivastava, Shruti Srivastava, ... Poonam Parashar in Malarial Drug Delivery Systems
    Chapter 2023
  10. Malaria – Current Treatment Options

    Malaria diseases are caused by Plasmodium, either P. falciparum or non-P. falciparum requires antimalarial treatment guidelines. Artemisinin-based...
    Dita Maria Virginia, Ranjita Shegokar, Yashwant Pathak in Malarial Drug Delivery Systems
    Chapter 2023
  11. Antimalarial Drug Resistance: Trends, Mechanisms, and Strategies to Combat Antimalarial Resistance

    Malaria is among the most prevalent parasite infections caused by Plasmodium genus. According to the most recent data available for the year 2020,...
    Chirag A. Patel, Sonal Pande, ... Sai H. S. Boddu in Malarial Drug Delivery Systems
    Chapter 2023
  12. Liposomal Drug Delivery in Malaria

    Malaria is one of the greatest health challenges worldwide and produces a great challenge to formulation scientists. Poor rate of development in the...
    Hemanga Hazarika, Harshita Krishnatreyya, ... Kamaruz Zaman in Malarial Drug Delivery Systems
    Chapter 2023
  13. Polymers, Particles and Conjugates

    Due to the inability to dose glucocorticoid receptor modulators (GRMs) chronically as a result of their unwanted side effects, the use of polymers,...
    Chapter 2023
  14. Prodrugs

    Prodrugs are a widely deployed strategy for medical chemists. Introduction of the prodrug typically moderates the physicochemical properties of the...
    Chapter 2023
  15. Tailoring Vaccines for Older Individuals: Aging of the Immune System and the Impact on Vaccine Efficacy

    Tailoring vaccines to the older population (>65 yrs) is an emerging subject that has gained momentum over the past decade. The vaccine efficacy of a...
    Shazia Bashir, Maria Wilson, ... Sudaxshina Murdan in Pharmaceutical Formulations for Older Patients
    Chapter 2023
  16. 3D Printing: Advancements in the Development of Personalised Pharmaceuticals for Older Adults

    Three-dimensional (3D) printing is a revolutionary additive manufacturing technology that constructs objects layer-by-layer. This versatile...
    Atheer Awad, Patricija Januskaite, ... Abdul W. Basit in Pharmaceutical Formulations for Older Patients
    Chapter 2023
  17. The Ageing Microbiome, Pharmaceutical Considerations, and Therapeutic Opportunities

    Research in recent years has illuminated the importance of the microbiome for human wellbeing and healthy ageingHealthy ageing. Numerous age-related...
    Alessia Favaron, Laura E. McCoubrey, ... Mine Orlu in Pharmaceutical Formulations for Older Patients
    Chapter 2023
  18. Starting Materials for Manufacturing the Biopharmaceutical Drug Substance

    Starting materials (also referred to as source materials) are the starting point for cGMP manufacturing of the biopharmaceutical drug substance. Some...
    Chapter 2023
  19. New Drugs in Synthesis Research for Viral Diseases

    In 1901, the yellow fever virus was one of the first viruses to be discovered by humans. Since then, over a century of research has been dedicated...
    Justin O. Ortiz, Jeffrey B. Brown, ... Charles Preuss in Infectious Diseases Drug Delivery Systems
    Chapter 2023
  20. Hepatitis C: Exploration of Diseases, Diagnosis, and Treatment Strategies

    By reading this chapter, readers will be able to understand what is hepatitis and how it affects different patients, and on prior treatment,...
    Laiba Masood, Nayyer Islam, ... Sana Hanif in Infectious Diseases Drug Delivery Systems
    Chapter 2023
Did you find what you were looking for? Share feedback.